Measures of blood pressure and myocardial infarction in treated hypertensive patients

J Fang1, S Madhavan, H Cohen

  • 1Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, New York 10461, USA.

Insights

Pulse pressure, the difference between systolic and diastolic blood pressure, is a key indicator for identifying hypertensive patients at high risk of myocardial infarction. This finding aids in early risk stratification for cardiovascular events.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Epidemiology

Background:

  • Hypertension is a major risk factor for cardiovascular diseases, including myocardial infarction.
  • Identifying specific blood pressure parameters that predict myocardial infarction risk in treated hypertensive patients is crucial for effective management.

Purpose of the Study:

  • To determine entry characteristics associated with subsequent myocardial infarction in treated hypertensive patients.
  • To evaluate the predictive value of different blood pressure measures for myocardial infarction risk.

Main Methods:

  • A nested case-control and cohort study design was employed.
  • 5730 participants from a hypertension control program were analyzed.
  • Univariate and multivariate analyses, including logistic regression, were used to assess risk factors.

Main Results:

  • Higher cholesterol and a history of diabetes were associated with myocardial infarction in univariate analysis.
  • Initial systolic blood pressure and pulse pressure were significantly higher in myocardial infarction cases.
  • Initial pulse pressure emerged as the sole independent predictor of myocardial infarction after multivariate adjustment.

Conclusions:

  • Elevated pulse pressure is a powerful, independent predictor of subsequent myocardial infarction in hypertensive individuals.
  • Measuring pulse pressure at baseline can help identify high-risk patients for targeted interventions.
  • This finding emphasizes the importance of pulse pressure in cardiovascular risk assessment for hypertensive populations.
Abstract

Related Concept Videos

Assessment of blood pressure in brachial artery(two-step method)01:23

Assessment of blood pressure in brachial artery(two-step method)

Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
Special considerations while measuring blood pressure01:28

Special considerations while measuring blood pressure

When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Measurement of Blood Pressure01:17

Measurement of Blood Pressure

Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a stethoscope.
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...